Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Last updated: November 22, 2022
Sponsor: ADIR Association
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Disease

Treatment

N/A

Clinical Study ID

NCT05372926
HighFlowMusc
  • Ages > 18
  • All Genders

Study Summary

in this study, the investigators aim to describe the effects of highflow nasal canulae oxygen therapy (HFNC) on respiratory muscle function during exercise in patients with fibrosing interstitial lung diseases (ILD) during an endurance test

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Cared for as part of a respiratory rehabilitation program (ADIR association)
  • Presenting diffuse fibrosing interstitial pneumonitis, documented by CT scan data andwhatever its etiology
  • Presenting severe hypoxemia in ambient air (SpO2<90%) during an exercise test (6-minute walk test or functional exercise test)

Exclusion

Exclusion Criteria:

  • Patient with a contraindication to carrying out a respiratory rehabilitation program
  • Patient having presented an exacerbation of PID, pneumothorax or pneumomediastinum inthe 3 months preceding potential inclusion
  • Tracheostomized patient
  • Patient with a contraindication to the placement of a nasogastric tube
  • Pregnant or breastfeeding women or women of childbearing age without effective meansof contraception (a pregnancy test will be carried out)
  • Protected adult patient (guardianship or curatorship)
  • Patient deprived of liberty by court or administrative decision
  • Refusal of patient participation or consent

Study Design

Total Participants: 16
Study Start date:
November 22, 2022
Estimated Completion Date:
November 23, 2024

Connect with a study center

  • ADIR association

    Bois-Guillaume, 76230
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.